Spotlight on Eptifibatide in Patients with Acute Coronary Syndromes and/or Undergoing Percutaneous Coronary Intervention

Author： Curran Monique P. Keating Gillian M.

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.20, Iss.1, 2006-01, pp. : 63-65

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spotlight on Fondaparinux Sodium in Acute Coronary Syndromes

By Blick Stephanie K.A. Orman Jennifer S. Wagstaff Antona J. Scott Lesley J.

BioDrugs, Vol. 22, Iss. 6, 2008-01 ,pp. : 413-415

Adis International

Access to resources Recommend Favorite

The acute coronary syndromes: advances in medical and interventional management

By Hill J Curzen N

Clinical Intensive Care, Vol. 11, Iss. 1, 2000-02 ,pp. : 3-12

Ashgate Publishing Ltd

Access to resources Recommend Favorite

What do we know about the long term medication adherence in patients following percutaneous coronary intervention?

By Fernandez Ritin Davidson Patricia Griffiths Rhonda Juergens Craig Salamonson Yenna

The Australian Journal of Advanced Nursing, Vol. 25, Iss. 2, 2007-02 ,pp. : 53-61

Australian Nursing Federation

Access to resources Recommend Favorite

Angiotensin converting enzyme DD genotype affects the changes of plasma plasminogen activator inhibitor-1 activity after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction patients

By Prisco D.

International Journal of Clinical & Laboratory Research, Vol. 30, Iss. 4, 2000-12 ,pp. : 179-185

Springer Publishing Company

Access to resources Recommend Favorite

Place des statines dans les accidents coronaires aigus: Statin Therapy in Acute Coronary Syndromes

By Lablanche Jean-Marc

Therapie, Vol. 58, Iss. 1, 2003-01 ,pp. : 59-62

Adis International

Access to resources Recommend Favorite